Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IBRX | Common Stock | Options Exercise | $0 | +57.2K | +1.89% | $0.00 | 3.09M | Sep 1, 2023 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | IBRX | Restricted Stock Units | Options Exercise | $0 | -57.2K | -50% | $0.00 | 57.2K | Sep 1, 2023 | Common Stock | 57.2K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of ImmunityBio, Inc. common stock. |
F2 | Subject to the reporting person's continuing to be a Service Provider (as defined in the Amended and Restated 2015 Equity Incentive Plan) through each applicable vesting date, 57,199 of the RSUs subject to the award vested on September 1, 2023 and 57,200 of the RSUs subject to the award shall vest on January 31, 2024. |